Delays to IM model approvals causing ‘anxiety’ for MetLife

Isda AGM: US insurer says regulators unprepared to accept docs where model approval is obligatory

Metlife-building

Buy-side firms caught in the fifth wave of non-cleared margin rules are growing anxious about their ability to adopt the standard initial margin model, or Simm, in jurisdictions where they are subject to model governance requirements, as the pace of approvals has stalled while anticipated relief is yet to materialise.

Some larger phase five firms plan to use internal models to calculate their own initial margin requirements. These models do not require approval by US regulators, but they need

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: